Clinical Trial Update: Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports on the safety and efficacy of RC-1291 HCl in patients with cancer-related anorexia and weight loss (cancer cachexia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• RC-1291 HCl (RC-1291 hydrochloride)

Snippet

Sponsor: Helsinn Therapeutics (U.S.), Inc | Conditions: Cancer Cachexia | Phase 2 | Status: COMPLETED